Comparative Analysis of the Efficacy of Different Regimens of 12 Months Rifaximin-Alfa Therapy in Patients with Liver Cirrhosis and Minimal Hepatic Encephalopathy.

Conclusions All study parameters, including quality of life, number connection test, symptoms associated with MHE, blood ammonia level showed a positive trend in the general population that completed the study according to the protocol.

also in 11,005 other papers

However, any changes in weight, both in the general population and in subgroups, did not reach statistical significance, on the basis of which it can be concluded that, during the year of observation, the weight of patients did not change significantly. 5.1.

also in 111,027 other papers